Quick Takeaways
- This page summarizes Michael Egholm's Form 4 filing for STANDARD BIOTOOLS INC. (LAB).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 05 Aug 2025, 18:23.
Michael Egholm - 01 Aug 2025 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)
- Signature
- /s/ Michael Egholm by Tomone Tanaka, Attorney-in-Fact
- Issuer symbol
- LAB
- Transactions as of
- 01 Aug 2025
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 05 Aug 2025, 18:23:22 UTC
- Previous filing
- 30 May 2025
- Next filing
- 22 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Michael Egholm filed Form 4 for STANDARD BIOTOOLS INC. (LAB) on 05 Aug 2025."
What Changed
- Previous filing in this sequence was filed on 30 May 2025.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Egholm Michael | President & CEO, Director | C/O STANDARD BIOTOOLS INC., 2 TOWER PLACE, STE 2000, SOUTH SAN FRANCISCO | /s/ Michael Egholm by Tomone Tanaka, Attorney-in-Fact | 05 Aug 2025 | 0001559779 |
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LAB | Common Stock | Award | $0 | +3,000,000 | +110% | $0.000000 | 5,736,285 | 01 Aug 2025 | Direct | F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Represents Restricted Stock Units ("RSUs") that vest as to 25% of the RSUs on August 1, 2026, with the remaining 75% of the RSUs vesting in three equal annual installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. |
| F2 | Includes 5,000 shares previously acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan. |